loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2012_289___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Fresenius Kabi Oncology Limited

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Biopharma Group offers CDMO services with expertise in contract R&D for dried products & liquid formulations.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN (1)

    filter

    01 Ropivacaine hydrochloride monohydrate (1)

    filter

    01 India (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    FRESENIUS KABI ONCOLOGY LIMITED Kal...

    Contact Supplier
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ropivacaine hydrochloride monohydrate

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2012-289 - Rev 00
    Withdrawn by Holder
    Chemical
    2019-03-21
    2024-03-06
    2335
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2012-289 - Rev 00 of Fresenius Kabi Oncology Limited Kalyani In

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2012-289 - Rev 00 of Fresenius Kabi Oncology Limited Kalyani In 1

    20

    Fresenius Kabi Oncology Limited Kalyani In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.

    One of their significant offerings is Ropivacaine hydrochloride monohydrate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2012-289 - Rev 00

    This Chemical Type CEP, issued on March 21, 2019, remains in force until March 06, 2024, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2335 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY